IRADIMED CORPORATION (IRMD) Gross margin 2016–2025
IRADIMED CORPORATION (IRMD) gross margin by fiscal year — reported gross profit divided by reported revenue.
76.7%FY2025 · since FY2016: 81.1% → 76.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 76.7% | -0.2 pp |
| FY2024 | 76.9% | +0.4 pp |
| FY2023 | 76.5% | -0.9 pp |
| FY2022 | 77.4% | +0.8 pp |
| FY2021 | 76.6% | +2.3 pp |
| FY2020 | 74.3% | -2.8 pp |
| FY2019 | 77.1% | +0.8 pp |
| FY2018 | 76.3% | +0.4 pp |
| FY2017 | 75.9% | -5.2 pp |
| FY2016 | 81.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IRMD financial trends
IRMD RevenueIRMD Net incomeIRMD Net marginIRMD Gross profitIRMD Operating incomeIRMD Operating marginIRMD Operating cash flowIRMD Free cash flowIRMD Capital expendituresIRMD Return on equityIRMD Stock buybacksIRMD Dividends paidIRMD Total assetsIRMD Total liabilitiesIRMD Shareholders’ equityIRMD overview →